Geode Capital Management, LLC Morpho Sys Ag Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.6 - $18.18 $34,253 - $72,410	3,983 Added 33.39%	15,911 $288,000
Q4 2023 Feb 13, 2024	BUY	$4.55 - $9.9 $54,272 - $118,087	11,928 New	11,928 $118,000
Q1 2021 May 12, 2021	SELL	$21.56 - $30.66 $175,390 - $249,419	-8,135 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$30.28 - $35.72 $73,126 - $86,263	-2,415 Reduced 22.89%	8,135 $255,000
Q2 2020 Aug 13, 2020	SELL	$24.08 - $33.35 $32,724 - $45,322	-1,359 Reduced 11.41%	10,550 $334,000
Q1 2020 May 14, 2020	BUY	$18.86 - $37.36 $91,659 - $181,569	4,860 Added 68.95%	11,909 $292,000
Q4 2019 Feb 13, 2020	BUY	$26.07 - $36.32 $183,767 - $256,019	7,049 New	7,049 $251,000

1.8M

14.7K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.